Shenzhen Neptunus Bioengineering Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 0.42%

Shenzhen Neptunus Bioengineering Co Ltd (000078) has an Asset Resilience Ratio of 0.42% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shenzhen Neptunus Bioengineering Co Ltd (000078) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥107.89 Million

≈ $15.79 Million USD Cash + Short-term Investments

Total Assets

CN¥25.73 Billion

≈ $3.77 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2025)

This chart shows how Shenzhen Neptunus Bioengineering Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Shenzhen Neptunus Bioengineering Co Ltd total assets.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen Neptunus Bioengineering Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Shenzhen Neptunus Bioengineering Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥107.89 Million	0.42%
Total Liquid Assets	CN¥107.89 Million	0.42%

Asset Resilience Insights

Limited Liquidity: Shenzhen Neptunus Bioengineering Co Ltd maintains only 0.42% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shenzhen Neptunus Bioengineering Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shenzhen Neptunus Bioengineering Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Shenzhen Neptunus Bioengineering Co Ltd (2001–2025)

The table below shows the annual Asset Resilience Ratio data for Shenzhen Neptunus Bioengineering Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.44%	CN¥116.80 Million ≈ $17.09 Million	CN¥26.33 Billion ≈ $3.85 Billion	+0.01pp
2024-12-31	0.44%	CN¥125.43 Million ≈ $18.35 Million	CN¥28.80 Billion ≈ $4.21 Billion	-0.17pp
2023-12-31	0.60%	CN¥194.41 Million ≈ $28.45 Million	CN¥32.30 Billion ≈ $4.73 Billion	+0.00pp
2022-12-31	0.60%	CN¥217.71 Million ≈ $31.86 Million	CN¥36.25 Billion ≈ $5.30 Billion	+0.51pp
2021-12-31	0.09%	CN¥35.21 Million ≈ $5.15 Million	CN¥37.60 Billion ≈ $5.50 Billion	-0.51pp
2020-12-31	0.60%	CN¥239.48 Million ≈ $35.04 Million	CN¥39.72 Billion ≈ $5.81 Billion	+0.57pp
2019-12-31	0.03%	CN¥13.16 Million ≈ $1.93 Million	CN¥41.17 Billion ≈ $6.02 Billion	+0.99pp
2018-12-31	-0.96%	CN¥-393.95 Million ≈ $-57.65 Million	CN¥41.13 Billion ≈ $6.02 Billion	+0.23pp
2017-12-31	-1.19%	CN¥-367.86 Million ≈ $-53.83 Million	CN¥30.86 Billion ≈ $4.52 Billion	+0.35pp
2016-12-31	-1.54%	CN¥-256.95 Million ≈ $-37.60 Million	CN¥16.66 Billion ≈ $2.44 Billion	+0.49pp
2015-12-31	-2.03%	CN¥-259.32 Million ≈ $-37.95 Million	CN¥12.76 Billion ≈ $1.87 Billion	+1.64pp
2014-12-31	-3.68%	CN¥-353.99 Million ≈ $-51.80 Million	CN¥9.63 Billion ≈ $1.41 Billion	-0.52pp
2013-12-31	-3.15%	CN¥-252.81 Million ≈ $-36.99 Million	CN¥8.02 Billion ≈ $1.17 Billion	-3.15pp
2012-12-31	0.00%	CN¥140.92K ≈ $20.62K	CN¥5.86 Billion ≈ $858.02 Million	0.00pp
2011-12-31	0.00%	CN¥132.87K ≈ $19.44K	CN¥4.84 Billion ≈ $707.56 Million	0.00pp
2010-12-31	0.00%	CN¥134.46K ≈ $19.68K	CN¥4.15 Billion ≈ $606.95 Million	0.00pp
2009-12-31	0.00%	CN¥125.41K ≈ $18.35K	CN¥3.16 Billion ≈ $463.10 Million	0.00pp
2008-12-31	0.00%	CN¥122.23K ≈ $17.89K	CN¥2.78 Billion ≈ $406.44 Million	+0.00pp
2007-12-31	0.00%	CN¥121.73K ≈ $17.81K	CN¥3.12 Billion ≈ $456.79 Million	+0.00pp
2006-12-31	0.00%	CN¥100.00K ≈ $14.63K	CN¥3.52 Billion ≈ $515.44 Million	-3.71pp
2005-12-31	3.72%	CN¥148.16 Million ≈ $21.68 Million	CN¥3.99 Billion ≈ $583.30 Million	-4.21pp
2004-12-31	7.92%	CN¥295.35 Million ≈ $43.22 Million	CN¥3.73 Billion ≈ $545.50 Million	+7.43pp
2003-12-31	0.49%	CN¥19.72 Million ≈ $2.89 Million	CN¥4.03 Billion ≈ $589.64 Million	-0.18pp
2002-12-31	0.67%	CN¥23.00 Million ≈ $3.37 Million	CN¥3.43 Billion ≈ $501.82 Million	-0.44pp
2001-12-31	1.11%	CN¥33.87 Million ≈ $4.96 Million	CN¥3.04 Billion ≈ $445.38 Million	--

pp = percentage points

About Shenzhen Neptunus Bioengineering Co Ltd

SHE:000078 China Drug Manufacturers - Specialty & Generic

Market Cap

$585.22 Million

CN¥4.00 Billion CNY

Market Cap Rank

#11531 Global

#3271 in China

Share Price

CN¥1.52

Change (1 day)

+0.00%

52-Week Range

CN¥1.29 - CN¥5.29

All Time High

CN¥9.81